Arivarasan Karunamurthy
Assistant Professor
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
.jpg "Aida Richardson, MD PhD photo")
Aida Richardson, MD PhD
Assistant Professor
Ann & Robert H. Lurie Children's Hospital of Chicago/Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
Description: Cell-free DNA (cfDNA) testing is at the forefront of cancer diagnostics and disease monitoring, providing a non-invasive method to detect genetic mutations, track tumor dynamics, and assess treatment responses. This session will delve into the latest advancements in cfDNA testing for both blood-based and non-blood-based samples, showcasing its applications in personalized medicine. We will examine the current applications, adoption challenges, and future directions of cfDNA testing, highlighting its profound impact on enhancing patient outcomes and facilitating more precise, targeted therapies.
If this session topic is of interest to you, please consider looking at the following course on AMP EDucation (AMPED™ Online)
Title: Bundle: Utility of Cell-free DNA in the Clinic: Current State and Future Directions
Please Click Here to Learn More.
Breakout Speaker: Christina Lockwood, PhD – University of Washington Medical Center
Breakout Speaker: Trevor Pugh, PhD, FACMG (he/him/his) – Princess Margaret Cancer Centre / Ontario Institute for Cancer Research